Celularity (CELU) Stock: Buy, Sell, or Hold?
CELU - Celularity Inc. Class A Common Stock
$1.31
0.04 (3.15%)
â˛
5d:
-7.09%
30d:
+68.38%
90d:
+74.13%
WAIT
LOW Confidence
Analysis Updated: Sep 18, 2026 12:00 AM ET
Earnings: Sep 04, 2026
0d
Get Alerted When CELU Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: CELU is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: CELU is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: CELU is currently trading at $1.31, which is considered fair relative to its 30-day fair value range of $0.77 to $1.67.
Technical Outlook: Technically, CELU is in a uptrend. Immediate support is located at $1.21, while resistance sits at $1.83. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: CELU scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.50 (+90.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CELU is in a uptrend. Immediate support is located at $1.21, while resistance sits at $1.83. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: CELU scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.50 (+90.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.77 -
$1.67
Company Quality Score
41/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
50.0%
Protect Your Profits
Holding CELU? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (15/100)
- BULLISH: Strong upward momentum (+3.1%)
- BULLISH: Trading 90.8% below Wall St target ($2.50)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.77 -
$1.67
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.21
Resistance Level
$1.83
Current Trend
Uptrend
Technical data as of
Sep 18, 2026
Fundamental Context
Wall Street Target
$2.50
(+90.8%)
Revenue Growth (YoY)
-77.4%
Earnings Growth (YoY)
-61.3%
Share & Embed Analysis
Last updated: September 19, 2026 3:46 AM ET
Data refreshes hourly during market hours. Next update: 4:46 AM
Data refreshes hourly during market hours. Next update: 4:46 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CELU showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$27 | 51 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 58 HOLD |
Advanced CELU Option Strategies
Professional options setups generated by AI based on today's CELU price and gamma walls.
